| Literature DB >> 32333295 |
Farzaneh Rafiee1, Fakhri Haghi1, Rahman Bikas2, Azam Heidari3, Mina Gholami1, Anna Kozakiewicz4, Habib Zeighami5.
Abstract
Quorum sensing (QS) inhibition by metal-antibiotic complexes is a promising strategy for the management and control of multidrug resistant Pseudomonas aeruginosa infections. We investigated the anti-quorum sensing activity of sub-minimum inhibitory concentration (sub-MIC) of copper(II) sulfate pentahydrate-ciprofloxacin (Cu-CIP) complex and free ciprofloxacin (free-CIP) against P. aeruginosa PAO1. Copper-CIP complex was synthesized and its characterization was assessed using spectroscopic methods and single crystal X-ray analysis. The effect of sub-MIC (1/4 and 1/16 MIC) concentrations of Cu-CIP and free-CIP on cell growth, biofilm formation, motility, alginate and pyocyanin production, H2O2 susceptibility and expression of QS circuit genes lasI and lasR in PAO1 was determined. Minimum inhibitory concentration of Cu-CIP complex and free-CIP was determined as 0.125 µg/ml. Copper-CIP complex did not show significant effect on the cell growth at concentrations of 1/4 and 1/16 MIC. However, sub-MIC concentrations (1/4 and 1/16 MIC) of Cu-CIP showed the significant reduction in violacein production, motility, biofilm formation, alginate and pyocyanin production and sensitivity to H2O2 in a concentration dependent manner (P < 0.001). Copper-CIP at the concentration of 1/4 MIC showed the greatest reduction in lasI and lasR transcriptional expression (89.5% and 96.2% respectively). Considering the biological effects of Cu-CIP complex and its inhibitory activity on QS related virulence traits at low concentrations (0.03 and 0.007 µg/ml), it may be used as an effective approach in the management of infections caused by P. aeruginosa.Entities:
Keywords: Ciprofloxacin; Metal complex; Pseudomonas aeruginosa; Quorum sensing
Year: 2020 PMID: 32333295 PMCID: PMC7182649 DOI: 10.1186/s13568-020-01017-3
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Crystallographic data and refinement details for Cu-CIP
| Compound | Cu-CIP |
|---|---|
| Formula | C17H32CuFN3O12S |
| 609.08 | |
| Crystal shape, color | Cubic, green |
| Crystal size/mm3 | 0.30 × 0.24 × 0.13 |
| λ/Å | 0.71073 (Mo |
| Crystal system | Monoclinic |
| Space group | |
| 15.9488 (12) | |
| 11.0141(9) | |
| 14.6494 (12) | |
| 106.958 (9) | |
| 2461.4 (4) | |
| 4 | |
| 1.644 | |
| 1.05 | |
| 1268 | |
| 2.3–28.6 | |
− 20 → 20 − 14 → 14 − 19 → 18 | |
| Measured reflections | 16,651 |
| Independent reflections | 5682 |
| Reflections with | 4365 |
| 0.038 | |
| 0.041 | |
| 0.126 | |
| 1.06 | |
| Abs. correction | Analytical |
| Parameters | 334 |
| Restraints | 0 |
| Δρmax/Δρmin | 0.74 −0.65 |
Fig. 1The molecular structure of Cu-CIP with atom labeling. Pink dashed lines show hydrogen bond interactions
Selected bond lengths (Å) and bond angles (°) in the crystal structure of Cu-CIP
| Bond | Length/Å | Bond | Angle/° |
|---|---|---|---|
| Cu1–O20 | 1.9121(18) | O20–Cu1–O23 | 92.86(8) |
| Cu1–O23 | 1.917(2) | O20–Cu1–O27 | 164.11(10) |
| Cu1–O27 | 1.956(2) | O23–Cu1–O27 | 88.95(9) |
| Cu1–O28 | 1.969(2) | O20–Cu1–O28 | 86.14(8) |
| Cu1–O24 | 2.256(3) | O23–Cu1–O28 | 169.78(10) |
| C8–F1 | 1.354(3) | O27–Cu1–O28 | 89.28(9) |
| C2–N3 | 1.492(3) | O20–Cu1–O24 | 103.45(10) |
| N3–C4 | 1.482(3) | O23–Cu1–O24 | 97.15(11) |
| N13–C17 | 1.343(3) | O27–Cu1–O24 | 91.97(10) |
| N13–C14 | 1.461(3) | O28–Cu1–O24 | 92.97(10) |
| C11–N13 | 1.401(3) |
Fig. 2Intermolecular hydrogen bond interactions (pink dashed lines) in the crystal structure of Cu-CIP
Fig. 3The effect of concentrations of 0.003 to 0.5 µg/ml of ciprofloxacin (CIP) and copper-ciprofloxacin complex (Cu-CIP) on cell growth of PAO1
Fig. 4Effect of subinhibitory concentrations (1/4 and 1/16 MIC) of ciprofloxacin (CIP) and copper-ciprofloxacin complex (Cu-CIP) on a biofilm formation and b swarming ■ and twitching □ motilities (*, significant, P < 0.05)
Fig. 5Effect of subinhibitory concentrations (1/4 and 1/16 MIC) of ciprofloxacin (CIP) and copper-ciprofloxacin complex (Cu-CIP) on a the alginate production, b pyocyanin production and c H2O2 susceptibility (*, significant, P < 0.05)
Fig. 6The subinhibitory concentrations (1/4 and 1/16 MIC) of ciprofloxacin (CIP) and copper-ciprofloxacin complex (Cu-CIP) inhibited QS regulated genes in treated PAO1 (*, significant, P < 0.05)